Related Experiment Video
Updated: May 21, 2026

Local Anesthetic Thoracoscopy for Undiagnosed Pleural Effusion
Published on: November 10, 2023
[Pleural empyema and lung abscess: current treatment options]
E Hecker1, S Hamouri, E Müller
1Thoraxzentrum Ruhrgebiet, Klinik für Thoraxchirurgie, Herne, Deutschland. e.hecker@evk-herne.de
This study reviews classifications and treatments for parapneumonic pleural empyema and lung abscesses. Management strategies range from antibiotics to surgery, tailored to disease stage and patient risk.
Area of Science:
- Pulmonology
- Thoracic Surgery
- Infectious Diseases
Context:
- Parapneumonic pleural empyema is classified by the American Thoracic Society (ATS), Light, and American College of Chest Physicians (ACCP) based on disease course, characteristics, and patient risk.
- Lung abscesses can be primary, aspiration-related, community-acquired, nosocomial, or occur in immunosuppressed individuals.
Purpose:
- To outline the staging and classification systems for parapneumonic pleural empyema.
- To describe therapeutic strategies for pleural empyema, including chest tubes, fibrinolysis, thoracoscopic debridement, and decortication.
- To discuss the management of lung abscesses, emphasizing antibiotic treatment and interventional options.
Summary:
- Pleural empyema management is guided by ATS, Light, and ACCP classifications, involving interventions like chest tubes and surgery.
- Most lung abscesses (90%) resolve with antibiotics; 10% require interventions like catheters or chest tubes, with only 1% needing surgery.
Impact:
- Provides a comprehensive overview of current diagnostic and therapeutic approaches for pleural empyema and lung abscesses.
- Highlights the importance of risk stratification and staging in guiding treatment decisions for better patient outcomes.
- Informs clinicians on the spectrum of interventions required, from conservative antibiotic therapy to advanced surgical procedures.
Related Concept Videos
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Pyelonephritis II: Diagnostic Studies and Management
Pneumonia III: Complications and Assessment
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Brain Abscess l: Introduction
